查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1628896

皮膚癌診斷市場，按測試類型、癌症類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Skin Cancer Diagnostics Market, By Test Type, By Cancer Type, By End-user, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年皮膚癌診斷市場規模為 91.145 億美元，2024 年至 2032 年複合年成長率為 5.90%。

皮膚癌診斷市場-市場動態

皮膚癌發生率上升

近幾十年來，皮膚癌一直是最常見的癌症類型之一，黑色素瘤和非黑色素瘤皮膚癌都變得越來越常見。據世界衛生組織 (WHO) 稱，預計 2020 年將報告超過 150 萬例新發皮膚癌病例。此外，歐盟委員會報告稱，2020 年，皮膚黑色素瘤佔歐盟 27 國所有新診斷癌症的 4%。它還導致 1.3% 的癌症死亡。皮膚癌是歐洲第六大最常被診斷出來的惡性腫瘤。隨著包括皮膚癌在內的其他癌症的盛行率在全球範圍內上升，預計全球皮膚癌診斷市場將在整個預測期內擴大。

皮膚癌診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球皮膚癌診斷市場在預測期內（2024-2032）每年將以 5.90% 左右的複合年成長率成長

根據測試類型細分，預計皮膚活體組織切片類別將在 2023 年顯示最大的市場佔有率

根據癌症類型細分，2023 年非黑色素瘤是領先的細分市場

按地區分類，北美是 2023 年的主要收入來源

皮膚癌診斷市場-細分分析：

全球皮膚癌診斷市場根據測試類型、癌症類型、最終用戶和地區進行細分。

根據測試類型，市場分為淋巴結活體組織切片、皮膚鏡檢查、影像測試、皮膚切片等。 2023年，皮膚活體組織切片細分市場佔據了大部分市場佔有率。皮膚切片檢查因其精確性、可靠性和適應性而成為皮膚癌診斷的黃金標準。它對於有效的皮膚癌篩檢和治療也至關重要。對皮膚活體組織切片的需求顯著增加，預計未來幾年將繼續增加。由於可以在顯微鏡下檢查令人擔憂的皮膚病變，因此該過程也可以得出結論性的診斷。此外，它還有助於確定皮膚癌的類型及其屬性，包括階段和嚴重程度，以及病變是否是惡性的。

依最終用戶分類，市場分為醫院和診所、實驗室等。到 2023 年，醫院和診所將佔據顯著的市場佔有率，在皮膚癌診斷行業佔據主導地位。在整個預測期內，該細分市場預計也將以最快的速度成長。皮膚癌盛行率的上升、診斷工具的改進以及早期診斷意識的增強都是促進皮膚癌診斷市場成長的因素。透過在醫院整合人工智慧和遠端皮膚病學，可以增加對醫院皮膚癌診斷服務的需求，這可以進一步提高診斷的可及性和準確性。

皮膚癌診斷市場 - 地理洞察

從地理上看，皮膚癌診斷市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區、中東和非洲地區。這些區域根據開展業務的國家進一步分類。

2023年，北美地區皮膚癌診斷市佔率最大。由於 Dermlite LLC、Castle Biosciences Inc. 和 Dermtech Inc. 等該地區領先公司在皮膚癌診斷產品的研發上投入了大量資金，北美皮膚癌診斷市場經歷了顯著擴張。此外，由於黑色素瘤發生率急劇上升，市場正在成長。此外，北美在皮膚癌診斷的發展方面處於領先地位，這為該地區的行業提供了巨大的潛在前景。

由於紫外線照射等環境變數不斷增加、人們對皮膚癌的認知不斷提高以及診斷技術的進步，預計亞太地區皮膚癌診斷市場將以最快的速度發展。隨著政府計劃鼓勵皮膚癌的早期識別和治療，醫療保健成本的上升和更容易獲得醫療設施進一步推動了市場的擴張。此外，預計這些皮膚癌藥物在亞太地區的監管批准，以及該地區發展中國家存在的規模龐大且不發達的市場，將支持亞太地區皮膚癌診斷市場的擴張。

皮膚癌診斷市場-競爭格局：

皮膚癌診斷市場的頂級公司包括 FOUNDATION MEDICINE, INC.、Castle Bioscience、DermTech、bioMerieux Inc.、DermaSensor, Inc. 等。重要的公司正在優先考慮維持高品質標準，並利用該地區當前的消費者基礎來進入相當大的市場。在市場上建立信譽的品牌可以從這種策略中受益。這些公司正在尖端基礎設施和技術方面進行大量投資，這使他們能夠有效地處理和分析大量樣本。為了增加市場佔有率，企業也與經銷商和其他企業進行許多策略活動。例如，診斷技術開發商SkylineDx於2024年1月獲得歐洲專利號3827101，標誌著癌症診斷和客製化治療的突破。該專利利用基因表現特徵水平描述了對原發性皮膚黑色素瘤患者進行分類和治療的新技術。

最新進展：

2024 年2 月：Quest Diagnostics 推出了MelaNodal Predict，這是一種非常複雜的預測性基因表現測試，旨在幫助黑色素瘤患者客製化治療選擇，黑色素瘤是一種皮膚癌，也是美國最流行的疾病之一。

2024 年 1 月：DermaSensor Inc. 的非侵入性皮膚癌評估系統獲得 FDA 批准，該系統採用人工智慧來識別常見的皮膚惡性腫瘤，如鱗狀細胞癌、基底細胞癌和黑色素瘤。這款無線手持裝置採用 FDA 批准的演算法，可提供快速、客觀的資料，使醫生能夠評估可疑病變，而無需進行侵入性治療。

2023 年 4 月：SkylineDx 和 NeraCare GmbH 宣布，他們將共同創建一項測試，使生命科學企業能夠更快地推出關鍵的黑色素瘤治療方法。

目錄

第 1 章：皮膚癌診斷市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按測試類型分類的皮膚癌診斷市場片段
    • 按癌症類型分類的皮膚癌診斷市場片段
    • 最終用戶的皮膚癌診斷市場片段
    • 按國家/地區分類的皮膚癌診斷市場片段
    • 按地區分類的皮膚癌診斷市場片段
  • 競爭洞察

第 3 章：皮膚癌診斷主要市場趨勢

  • 皮膚癌診斷市場促進因素
    • 市場促進因素的影響分析
  • 皮膚癌診斷市場限制
    • 市場限制影響分析
  • 皮膚癌診斷市場機會
  • 皮膚癌診斷市場未來趨勢

第 4 章：皮膚癌診斷產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：皮膚癌診斷市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：皮膚癌診斷市場格局

  • 2023 年皮膚癌診斷市佔分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：皮膚癌診斷市場 - 按測試類型

  • 概述
    • 按測試類型分類的細分市場佔有率分析
    • 淋巴結活體組織切片
    • 皮膚鏡檢查
    • 影像學檢查
    • 皮膚切片
    • 其他

第 8 章：皮膚癌診斷市場 - 按癌症類型

  • 概述
    • 按癌症類型分類的細分市場佔有率分析
    • 黑色素瘤
    • 非黑色素瘤

第 9 章：皮膚癌診斷市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 醫院和診所
    • 實驗室
    • 其他

第 10 章：皮膚癌診斷市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美皮膚癌診斷主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按測試類型）
    • 北美市場規模和預測（按癌症類型）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲皮膚癌診斷主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按測試類型）
    • 歐洲市場規模和預測（按癌症類型）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 英國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區皮膚癌診斷主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 按測試類型分類的亞太市場規模和預測
    • 亞太地區市場規模和預測（按癌症類型）
    • 亞太地區市場規模和預測（按最終用戶）
    • 印度
    • 中國
    • 韓國
    • 日本
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲皮膚癌診斷主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模和預測（按測試類型）
    • 拉丁美洲市場規模與預測（按癌症類型）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲皮膚癌診斷主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按測試類型）
    • 中東和非洲市場規模及預測（按癌症類型）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 皮膚癌診斷產業

  • 競爭儀表板
  • 公司簡介
    • FOUNDATION MEDICINE, INC.
    • Castle Bioscience
    • DermTech
    • bioMerieux Inc.
    • DermaSensor, Inc.
    • Quest Diagnostics Incorporated.
    • NeoGenomics Laboratories
    • SkylineDx
    • Abbott
    • F Hoffmann-La Roche Ltd
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV4429

REPORT HIGHLIGHT

Skin Cancer Diagnostics Market size was valued at USD 9,114.5 Million in 2023, expanding at a CAGR of 5.90% from 2024 to 2032.

The procedure for identifying and diagnosing skin cancer is called skin cancer diagnostics. This encompasses a number of methods, including molecular pathology, histology, immunohistochemistry, electron microscopy, physical examination, and biopsy. Among the cancers that impact the skin is skin cancer. Skin cancer comes in three primary forms: squamous cell carcinoma, malignant melanoma, and basal cell carcinoma. Globally, the incidence of skin cancer is rising due to factors including ageing populations and prolonged UV exposure, which is driving the market for skin cancer diagnostics. This is driving the need for efficient diagnostic tools. Furthermore, more people are being encouraged to have regular tests for skin cancer due to rising public awareness and educational initiatives regarding the significance of early diagnosis.

Skin Cancer Diagnostics Market- Market Dynamics

Rising Incidence of Skin Cancer

Skin cancer has been one of the most common types of cancer in recent decades, with both melanoma and non-melanoma skin cancers becoming more common. Over 1.5 million new instances of skin cancer were anticipated to be reported in 2020, according to the World Health Organization (WHO). In addition, the European Commission reports that in 2020, cutaneous melanoma accounted for 4% of all new cancer diagnoses in the EU-27. It was also responsible for 1.3% of all deaths from cancer. Skin cancer is the sixth most often diagnosed malignancy in Europe. The global market for skin cancer diagnostics is expected to expand throughout the forecast period as the prevalence of other cancers, including skin cancer, rises worldwide.

Skin Cancer Diagnostics Market- Key Insights

As per the analysis shared by our research analyst, the global Skin Cancer Diagnostics Market is estimated to grow annually at a CAGR of around 5.90% over the forecast period (2024-2032)

Based on test type segmentation, the skin biopsy category was predicted to show maximum market share in the year 2023

Based on cancer type segmentation, the non-melanoma was the leading segment in 2023

On the basis of region, North America was the leading revenue generator in 2023

Skin Cancer Diagnostics Market- Segmentation Analysis:

The Global Skin Cancer Diagnostics Market is segmented on the basis of Test Type, Cancer Type, End-user, and Region.

Based on test type, the market is segmented into Lymph Node Biopsy, Dermatoscopy, Imaging Tests, Skin Biopsy, and Others. The skin biopsy segment accounted for the majority of the market share in 2023. The most popular material for screening is skin biopsy, a medical technique in which a small sample of skin tissue is taken from the body. Skin biopsy is the gold standard for skin cancer diagnosis because of its precision, dependability, and adaptability. It is also essential for efficient skin cancer screening and treatment. The need for skin biopsies has increased significantly and is anticipated to continue to rise over the next several years. Because the worrisome skin lesion can be examined under a microscope, the process also yields a conclusive diagnosis. In addition, it assists in determining the type of skin cancer and its attributes, including stage and severity, as well as whether the lesion is malignant.

By end-user, the market is segmented into hospitals and clinics, laboratories, and others. With a significant market share in 2023, hospitals and clinics dominated the skin cancer diagnostics industry. Throughout the forecast period, this segment is also anticipated to increase at the fastest rate. The rising prevalence of skin cancer, improvements in diagnostic tools, and growing awareness of early diagnosis are all factors contributing to the skin cancer diagnostics market growth. The need for hospital-based skin cancer diagnostic services can be increased by integrating AI and teledermatology in hospitals, which can further improve diagnostic accessibility and accuracy.

Skin Cancer Diagnostics Market- Geographical Insights

Geographically, the Skin Cancer Diagnostics Market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

In 2023, North America's share in the regional skin cancer diagnostics market was the greatest. Due to significant expenditures made in the research and development of skin cancer diagnostics products by leading companies operating in the region, including Dermlite LLC, Castle Biosciences Inc., and Dermtech Inc., the North American skin cancer diagnostics market has experienced significant expansion. Additionally, the market is growing due to the sharp rise in melanoma incidence. Furthermore, North America is leading the way in the development of skin cancer diagnostics, which offers significant potential prospects for the region's industry.

The market for skin cancer diagnostics is expected to develop at the quickest rate in the Asia Pacific due to rising environmental variables like UV exposure, growing awareness of skin cancer, and improvements in diagnostic technology. Along with government programs encouraging early identification and treatment of skin cancer, rising healthcare costs and easier access to medical facilities further fuel market expansion. Additionally, it is projected that the regulatory approvals for these skin cancer medications in the Asia Pacific, together with the existence of a sizable and underdeveloped market in the region's developing nations, will support the expansion of the skin cancer diagnostics market in Asia Pacific.

Skin Cancer Diagnostics Market- Competitive Landscape:

Among the top companies in the skin cancer diagnostics market are FOUNDATION MEDICINE, INC., Castle Bioscience, DermTech, bioMerieux Inc., DermaSensor, Inc., and others. Important firms are prioritizing upholding high standards of quality and gaining access to a sizable market by using the region's current consumer bases. Brands that have established credibility in the marketplace can benefit from this tactic. These companies are making significant investments in cutting-edge infrastructure and technology, which enables them to process and analyze a high volume of samples efficiently. In order to increase their market presence, businesses also engage in a number of strategic activities with distributors and other businesses. For instance, the diagnostics technology developer SkylineDx was granted European Patent No. 3827101 in January 2024, marking a breakthrough in cancer diagnosis and tailored therapy. Using gene expression signature levels, the patent describes new techniques for classifying and treating individuals with primary cutaneous melanoma.

Recent Developments:

February 2024: MelaNodal Predict, a very sophisticated predictive gene expression test, was introduced by Quest Diagnostics to assist in customizing treatment choices for patients with melanoma, a type of skin cancer and one of the most prevalent diseases in the United States.

January 2024: DermaSensor Inc. was granted FDA approval for its noninvasive skin cancer assessment system, which employs artificial intelligence to identify common skin malignancies like SCC, basal cell carcinoma, and melanoma. Using an FDA-approved algorithm, the wireless, handheld gadget gives quick, objective data, enabling doctors to assess suspected lesions without the need for intrusive treatments.

April 2023: SkylineDx and NeraCare GmbH announced that they will work together to create a test that would allow life science businesses to launch critical melanoma treatments more quickly.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SKIN CANCER DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • FOUNDATION MEDICINE, INC.
  • Castle Bioscience
  • DermTech
  • bioMerieux Inc.
  • DermaSensor, Inc.
  • Quest Diagnostics Incorporated.
  • NeoGenomics Laboratories
  • SkylineDx
  • Abbott
  • F Hoffmann-La Roche Ltd
  • Others

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Lymph Node Biopsy
  • Dermatoscopy
  • Imaging Tests
  • Skin Biopsy
  • Others

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY CANCER TYPE- MARKET ANALYSIS, 2019 - 2032

  • Melanoma
  • Non-Melanoma

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Laboratories
  • Others

GLOBAL SKIN CANCER DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Skin Cancer Diagnostics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Skin Cancer Diagnostics Market Snippet by Test Type
    • 2.1.2. Skin Cancer Diagnostics Market Snippet by Cancer Type
    • 2.1.3. Skin Cancer Diagnostics Market Snippet by End-user
    • 2.1.4. Skin Cancer Diagnostics Market Snippet by Country
    • 2.1.5. Skin Cancer Diagnostics Market Snippet by Region
  • 2.2. Competitive Insights

3. Skin Cancer Diagnostics Key Market Trends

  • 3.1. Skin Cancer Diagnostics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Skin Cancer Diagnostics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Skin Cancer Diagnostics Market Opportunities
  • 3.4. Skin Cancer Diagnostics Market Future Trends

4. Skin Cancer Diagnostics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Skin Cancer Diagnostics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Skin Cancer Diagnostics Market Landscape

  • 6.1. Skin Cancer Diagnostics Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Skin Cancer Diagnostics Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
    • 7.1.2. Lymph Node Biopsy
    • 7.1.3. Dermatoscopy
    • 7.1.4. Imaging Tests
    • 7.1.5. Skin Biopsy
    • 7.1.6. Others

8. Skin Cancer Diagnostics Market - By Cancer Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Cancer Type, 2023 & 2032 (%)
    • 8.1.2. Melanoma
    • 8.1.3. Non-Melanoma

9. Skin Cancer Diagnostics Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2023 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Laboratories
    • 9.1.4. Others

10. Skin Cancer Diagnostics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Skin Cancer Diagnostics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Skin Cancer Diagnostics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Skin Cancer Diagnostics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Skin Cancer Diagnostics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Skin Cancer Diagnostics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Cancer Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Skin Cancer Diagnostics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. FOUNDATION MEDICINE, INC.
    • 11.2.2. Castle Bioscience
    • 11.2.3. DermTech
    • 11.2.4. bioMerieux Inc.
    • 11.2.5. DermaSensor, Inc.
    • 11.2.6. Quest Diagnostics Incorporated.
    • 11.2.7. NeoGenomics Laboratories
    • 11.2.8. SkylineDx
    • 11.2.9. Abbott
    • 11.2.10. F Hoffmann-La Roche Ltd
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us